FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: A prospective study
- 28 February 2011
- journal article
- clinical trial
- Published by Elsevier BV in Archives of Gerontology and Geriatrics
- Vol. 52 (1), 89-93
- https://doi.org/10.1016/j.archger.2010.02.006
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- FOLFOX2 in the Treatment of Advanced Colorectal Cancer: A Comparison Between Elderly and Middle Aged PatientsJournal of Chemotherapy, 2008
- Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer TreatmentJNCI Journal of the National Cancer Institute, 2005
- Capecitabine plus oxaliplatin for the first‐line treatment of elderly patients with metastatic colorectal carcinomaCancer, 2005
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- CANCER IN THE FRAIL PATIENT: A Coming EpidemicHematology/Oncology Clinics of North America, 2000
- Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil RegimenJournal of Clinical Oncology, 1999
- Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimenAnnals Of Oncology, 1998
- Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapyCancer Chemotherapy and Pharmacology, 1998
- Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancerEuropean Journal Of Cancer, 1997
- Toxicity and Therapeutic Response to Chemotherapy in Patients Aged 70 Years or Older with Advanced CancerAmerican Journal of Clinical Oncology, 1996